Veracyte | VCYT - Sales Revenues

Stock Price
36.16
Daily Change
1.30 3.73%
Monthly
-19.84%
Yearly
-12.99%
Q1 Forecast
36.91

Veracyte reported $131.9M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Agilent USD 1.86B 123M Sep/2025
Arrowhead Research USD 264.03M 7.56M Dec/2025
Bruker USD 860.5M 63.1M Sep/2025
Exact Sciences USD 851M 39.9M Sep/2025
Illumina USD 1.16B 80M Dec/2025
Laboratory Of America USD 3.56B 30M Sep/2025
Ligand Pharmaceuticals USD 115.46M 67.83M Sep/2025
Myriad Genetics USD 205.7M 7.4M Sep/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Siemens EUR 21.43B 2.05B Sep/2025
Sonic Healthcare AUD 4.98B 311M Jun/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Veracyte USD 131.9M 1.74M Sep/2025
Waters USD 800M 29M Sep/2025